Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002091297 | SCV002384036 | likely benign | Bethlem myopathy 1A | 2021-02-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002993481 | SCV003720701 | uncertain significance | Inborn genetic diseases | 2021-10-18 | criteria provided, single submitter | clinical testing | The c.2548C>T (p.H850Y) alteration is located in exon 28 (coding exon 27) of the COL6A2 gene. This alteration results from a C to T substitution at nucleotide position 2548, causing the histidine (H) at amino acid position 850 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005025697 | SCV005661508 | uncertain significance | Myosclerosis; Bethlem myopathy 1B; Ullrich congenital muscular dystrophy 1B | 2024-04-02 | criteria provided, single submitter | clinical testing |